Highlights newsletter 1
This newsletter presents you the following key sessions:
3. L-glutamine reduces pain crises and other common events associated with sickle cell disease
4. Tinzaparin is more effective than warfarin in preventing clot recurrence in cancer patients
6. Comparative efficacy of ponatinib versus the sequential treatment of alternate second generation tyrosine kinase
inhibitors in the 3rd line setting